“CR1505 (loxiglumide; D ,L-4-(3,4-dichlorobenzoyl-amino)-5-(N-3-methoxypropyl-pentylam ino)-5- oxopentanoic acid), an antagonist of cholecystokinin receptors, inhibited pancreatic growth induced by long-term administation of pentagastrin , whereas pancreatic hypertrophy induced by bethanechol was not inhibited by CR1505.”